companydata.dkcompanydata.dk

AGC Biologics A/S: Financial statements 2023

CVR: 25950941

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,092,565,000 and a net result of DKK 243,869,000 compared with DKK 598,949,000 the year before. That is a decrease of 16.9% compared with the year before. The profit margin was 11.7%. Equity in the 2023 report amounted to DKK 307,426,000. The solvency ratio was 8.5%. The company had 956 employees in the financial year.

Revenue
DKK 2,092,565,000
Gross Profit
DKK 501,294,000
Profit/Loss
DKK 243,869,000
Equity
DKK 307,426,000
Total Assets
DKK 3,623,676,000
Employees
956

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20232.1B501.3M243.9M307.4M956
20222.5B937M598.9M661.3M894
20212.2B831.9M571.7M633.6M730
20201.5B452M278.5M339.7M441
2019996.1M257.1M154.3M215.1M377

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

AGC Biologics A/S: The 2022 annual report is outJun 29, 2023

AGC Biologics A/S has published its annual report for 2022. Revenue came to DKK 2,517,996,000, and the net result was DKK 598,949,000.

About AGC Biologics A/S

AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.

Source: annual report 2025, Danish Business Authority